scandenoside R3

scandenoside R1

Notoginsenoside R3

Vinaginsenoside R3

LONG R3 IGF-I RECOMBINANT ANALOG

(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-carboxybutanoyl]amino]propanoyl]amino]-4-carboxybutanoyl]amino]-4-carboxybutanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-3-phenylpr

Oxiranecarboxamide, 3-methyl-2-propyl-, (2R-cis)- (9CI)

4-((Cyclohexylamino)methyl)benzoic acid hydrochloride

1-(4-amino-1H-pyrazol-1-yl)but-3-yn-2-one

1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine

2-Methoxy-6-(pyrazol-1-yl)-benzonitrile

4-(2-Fluoro-3-hydroxyphenyl)-3-methylbenzaldehyde

1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-

(4-Methyl-tetrahydro-furan-2-yl)-methanol

N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide

4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde

tert-Butyl-DL-alanine